| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > PPC Publishing > The Learning Curve - Or the Learning Roller Coaster? |
|
Digg It - The Learning Curve - Or the Learning Roller Coaster?
When I first started using AdSense, I knew nothing about contextual advertising. It showed in my revenues. For the fi According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product rst few months I was making little more than a few dollars a day. I had to go through a long learning curve, experim ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in nting with formats, appearances and location. I had to test keywords and colors and fonts. I played around and gradua lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. lly my revenues rose until eventually they reached the happy levels they’re at today. When I think about how much mo here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ey I could have made during that learning period, I get goose bumps. I’m very glad I’m not in that position any more. d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro And I’m not too pleased about finding myself in danger of slipping back there every few weeks. It seems as though t ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc he online advertising world is changing all the time. Every month, Google makes a change that could have an effect on easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi revenues. Or some company brings out a new contextual advertising system. Or we discover some former secret about how nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically a system we’re already using works and rush to figure out what we can do with that knowledge. All of that requires m and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ore experimentation. For example, I’ve recently been playing with eMiniMalls. I’ve come up with some pretty good ide ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi s to make them generate maximum revenues but again, I’ve had to go through a fairly long learning curve to figure the ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a out. And while I was figuring them out, I had to make changes to websites that were already bringing in money with o dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod nly a vague idea of what the effects might be. I sometimes wonder if I shouldn’t just put up a website that I could cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin se specifically for experimentation. Instead of trying new strategies on sites that I knew worked, I could test them tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen n a practice site first and then incorporate whatever worked into my revenue-generating sites. That would certainly t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel save me from effectively gambling with my current revenues as I try to figure out ways to use all the new tools comin ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust online. But of course I’d only be losing all the revenues that that test site would be earning if I’d optimized it y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products roperly. Still, even if revenues do fall while I’m playing with the location of an eMiniMall ad or adjusting the for . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de mat of my AdSense units or trying to get different AdLinks to light up, the final result is usually a higher income l elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ter. I guess those revenue dips while we figure stuff out are just part of the capital investment we all have to make tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Manufacturing Capacity as a Commodity Open a Dollar Store - Be Sure to Establish A Hierarchy of Needs! Add Clickbank Products to your Site or Blog via RSS for Free!
|